This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...

MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a suspension of tiny crystals. Once under the skin, the crystals assemble into a drug ...

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

A Florida State University computational scientist is paving the way for future medical breakthroughs by developing ...

With the aging of the global population and the rising incidence of neuropsychiatric conditions, the demand for therapeutic drugs is increasing. Consequently, innovations relevant to these medications ...

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed ...

Sandra Gostynska and Augen Pioszak, Ph.D., of the University of Oklahoma are authors of a new paper in Science Signaling that sheds light on the hormone amylin and the receptors it targets in the ...

Developing therapies for rare diseases involves complex incentives, unique requirements, and often extensive patient engagement. The authors of RAPS’ Orphan Drug Development for Rare Diseases, Sundar ...

Name brand GLP-1 drugs like Ozempic and Wegovy have quickly become household names, akin to Tylenol or Advil, and their rise in popularity is only increasing. Originally developed to treat type 2 ...

As more continues to be understood about the health benefits associated with GLP-1 drugs, a growing body of science is aiming to answer whether the popular weight-loss medication can help with one of ...

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease ...